Results 141 to 150 of about 17,718 (201)

Similar short-term efficacy of oral levosulpiride and intravitreal ranibizumab in patients with diabetic macular oedema. [PDF]

Eye (Lond)
Adán-Castro E, Núñez-Amaro CD, Villarreal J, Islas IH, García-Roa M, López-Star E, García-Franco R, Robles-Osorio ML, Martínez de la Escalera G, Clapp C.   +9 more
europepmc   +1 more source

Effect of intravitreal VEGF inhibitors on renal-related adverse events in patients with diabetes mellitus: systematic review and meta-analysis. [PDF]

Front Pharmacol
Zheng Y, Zhang F, Li X, Zhang X, Zhong Y.   +4 more
europepmc   +1 more source

Hyperreflective Dots on SD-OCT: Implications for Predicting Treatment Outcomes in Diabetic Macular Edema. [PDF]

Diagnostics (Basel)
Li S, Li M, Sun A, Zhang H.
europepmc   +1 more source

Cost-effectiveness of anti-vascular endothelial growth factor and macular laser treatments for people with centre-involving diabetic macular oedema and central retinal thickness of at least 400 micrometres. [PDF]

Eye (Lond)
Luckham K, Tebbs H, Dadswell C, Yosef A, Claxton L, Kelley K, Taske N, Burgess PI, Dinah C, Lois N, Mohiuddin S.   +10 more
europepmc   +1 more source

Ranibizumab treatment improves the reading speed of patients with neovascular age-related macular degeneration: A nonrandomized clinical trial using the Radner reading chart

George Hayek, Dóra Reglődi, Christophe Goetz, Jean‐Marc Perone, Adrienne Csutak   +4 more
openalex   +1 more source

Macular morphology and response to ranibizumab treatment in patients with wet age-related macular degeneration

, 2016
Nikolaos Dervenis, Saad Younis
openalex   +2 more sources

Successful Cataract Surgery in a Patient with a Port Delivery System Implant for Diabetic Macular Edema. [PDF]

Case Rep Ophthalmol
Chu J, Haddadin RI, Gill M.
europepmc   +1 more source

Long-Term Changes in Submacular Choroidal Thickness after Intravitreal Ranibizumab Therapy for Neovascular Age-Related Macular Degeneration: 14-Mo Follow-Up

, 2019
Sibel İnan, Zeki Baysal, Ümit Ubeyt İnan   +2 more
openalex   +2 more sources

Twelve-Month Outcomes of Anti-VEGF Therapy for nAMD with Brolucizumab, Aflibercept, and Ranibizumab in the Polish National Registry: A Multicenter Database Study. [PDF]

J Clin Med
Teper S, Ledwoń D, Romaniszyn-Kania P, Sendecki A, Tuszy A, Nycz J, Mitas AW, Figurska M, Wylęgała E, Rękas M.   +9 more
europepmc   +1 more source

Potential Bias in Self-Controlled Case Series Design: Impact of Incident Versus Prevalent Scenarios of Exposure and Outcome. [PDF]

Pharmacoepidemiol Drug Saf
Jung K, Byun SJ, Lim G, Lee JE, Lee H, Kim JH, Shin JY.   +6 more
europepmc   +1 more source